EcoFlow also previews its residential energy systems customized for the U.S. market,and showcases its latest portable power stations and power banks
Jan 8, 2025
Demonstration of the new TI TDA4VPE-Q1 automotive system-on-chip with STRADVISION\'s production-ready SVNet 3D perception network for ADAS and autonomous driving
Jan 8, 2025
First-ever collaboration introduces a robust perception stack for automated driving STRADVISION\'s 3D Perception SVNet enables deep learning-based embedded perception algorithms using AMD Versal™ AI
Jan 8, 2025
Through this multi-year initiative,HCDC will tap on Docquity\'s digital capabilities and reach to arm over 3,000 HCPs across diverse fields with breakthroughs in preventive medicine
Jan 8, 2025
SINGAPORE,Jan. 6,2025-- Shanghai has emerged as the fastest growing destination for attracting international travelers from Asia,according to digital travel platformAgoda. The Chinese metropolis is f
Jan 8, 2025
SINGAPORE,Jan. 6,2025-- Digital Edge (Singapore) Holdings Pte Ltd. ("Digital Edge"),a leading developer and operator of interconnection and hyperscale edge data centers across Asia and portf
Jan 8, 2025
SHENZHEN,China,Jan. 6,2025-- Huawei Digital Power held the Top 10 Trends ofFusionSolar Launch 2025 with the theme of "Integrated Innovation for an Intelligent Future,Accelerating PV to Become the
Jan 8, 2025
SHANGRAO,China,Jan. 6,2025-- JinkoSolar Holding Co.,Ltd. (the "Company," or "JinkoSolar") (NYSE: JKS),one of the largest and most innovative solar module manufacturers in the world
Jan 8, 2025
HANGZHOU,China,Jan. 6,2025-- Cainiao,a global leader in e-commerce logistics and logistics technology,has recently launched its latest L4-level autonomous vehicle for public roads – the Cainiao Auton
Jan 8, 2025
Hyundai Motor Group celebrates New Year at Hyundai Motorstudio Goyang,emphasizing open communication with employees at flagship space
Jan 8, 2025
Newly published research,conducted by GenZInsights,affirms the in-app short-form contentopportunity formediacompaniesandstreamers
Jan 8, 2025
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody,will be the lead clinical program following the Company\'s portfolio prioritization
Jan 8, 2025
© TopicFashion Privacy Policy Contact us